MAPT and Alzheimer disease: In addition, we tested whether the epicenters of tau pathology (i.e., 10% of brain regions with highest baseline tau-PET positivity,) were more likely to be located in more globally connected regions in younger symptomatic AD patients (see Supplementary Fig. 1 for a mapping of epicenters; anatomical locations of the epicenters are labeled in the source data file).